Top Back to top

CAR-T cell treated patients registered in the EBMT Registry

by

EBMT centre members and national registries are requested to document CAR-T cell therapies

This is part of a long-term effort and commitment of EBMT, together with all interested stakeholders, to contribute to a full assessment of the medical value of this new category of medicinal products, including long-term safety and efficacy. Read the September News HERE

Number of CAR-T treated patients in the registry - October

 

Map Europe - Countries reporting CAR-T cell therapies